TY  - GEN
AU  - Aronne,L J
AU  - Tonstad,S
AU  - Moreno,M
AU  - Gantz,I
AU  - Erondu,N
AU  - Suryawanshi,S
AU  - Molony,C
AU  - Sieberts,S
AU  - Nayee,J
AU  - Meehan,A G
AU  - Shapiro,D
AU  - Heymsfield,S B
AU  - Kaufman,K D
AU  - Amatruda,J M
TI  - A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study
SN  - 1476-5497
PY  - 2010///1104
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Amides
KW  - administration & dosage
KW  - Anti-Obesity Agents
KW  - Body Mass Index
KW  - Body Weight
KW  - drug effects
KW  - Diet, Reducing
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Male
KW  - Metabolic Syndrome
KW  - drug therapy
KW  - Middle Aged
KW  - Obesity
KW  - Pyridines
KW  - Receptor, Cannabinoid, CB1
KW  - agonists
KW  - Risk Assessment
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1038/ijo.2010.21
ER  -